Literature DB >> 23017536

Interferon-Beta improves survival in enterovirus-associated cardiomyopathy.

Uwe Kühl, D Lassner, Jessica von Schlippenbach, Wolfgang Poller, Heinz-Peter Schultheiss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23017536     DOI： 10.1016/j.jacc.2012.06.026

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  32 in total

1.  Long noncoding RNA MALAT1-derived mascRNA is involved in cardiovascular innate immunity.

Authors:  Martina Gast; Blanche Schroen; Antje Voigt; Jan Haas; Uwe Kuehl; Dirk Lassner; Carsten Skurk; Felicitas Escher; Xiaomin Wang; Adelheid Kratzer; Katharina Michalik; Anna Papageorgiou; Tim Peters; Madlen Loebel; Sabrina Wilk; Nadine Althof; Kannanganattu V Prasanth; Hugo Katus; Benjamin Meder; Shinichi Nakagawa; Carmen Scheibenbogen; Heinz-Peter Schultheiss; Ulf Landmesser; Stefanie Dimmeler; Stephane Heymans; Wolfgang Poller
Journal:  J Mol Cell Biol       Date:  2016-01-27       Impact factor: 6.216

Review 2.  Coagulation, protease-activated receptors, and viral myocarditis.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  J Cardiovasc Transl Res       Date:  2013-11-08       Impact factor: 4.132

3.  Immunological and pathological consequences of coxsackievirus RNA persistence in the heart.

Authors:  Claudia T Flynn; Taishi Kimura; Kwesi Frimpong-Boateng; Stephanie Harkins; J Lindsay Whitton
Journal:  Virology       Date:  2017-12       Impact factor: 3.616

4.  Brazilian Society of Cardiology Guideline on Myocarditis - 2022.

Authors:  Marcelo Westerlund Montera; Fabiana G Marcondes-Braga; Marcus Vinícius Simões; Lídia Ana Zytynski Moura; Fabio Fernandes; Sandrigo Mangine; Amarino Carvalho de Oliveira Júnior; Aurea Lucia Alves de Azevedo Grippa de Souza; Bárbara Maria Ianni; Carlos Eduardo Rochitte; Claudio Tinoco Mesquita; Clerio F de Azevedo Filho; Dhayn Cassi de Almeida Freitas; Dirceu Thiago Pessoa de Melo; Edimar Alcides Bocchi; Estela Suzana Kleiman Horowitz; Evandro Tinoco Mesquita; Guilherme H Oliveira; Humberto Villacorta; João Manoel Rossi Neto; João Marcos Bemfica Barbosa; José Albuquerque de Figueiredo Neto; Louise Freire Luiz; Ludhmila Abrahão Hajjar; Luis Beck-da-Silva; Luiz Antonio de Almeida Campos; Luiz Cláudio Danzmann; Marcelo Imbroise Bittencourt; Marcelo Iorio Garcia; Monica Samuel Avila; Nadine Oliveira Clausell; Nilson Araujo de Oliveira; Odilson Marcos Silvestre; Olga Ferreira de Souza; Ricardo Mourilhe-Rocha; Roberto Kalil Filho; Sadeer G Al-Kindi; Salvador Rassi; Silvia Marinho Martins Alves; Silvia Moreira Ayub Ferreira; Stéphanie Itala Rizk; Tiago Azevedo Costa Mattos; Vitor Barzilai; Wolney de Andrade Martins; Heinz-Peter Schultheiss
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

Review 5.  Viral Myocarditis: Classification, Diagnosis, and Clinical Implications.

Authors:  Fabiola B Sozzi; Elisa Gherbesi; Andrea Faggiano; Eleonora Gnan; Alessio Maruccio; Marco Schiavone; Laura Iacuzio; Stefano Carugo
Journal:  Front Cardiovasc Med       Date:  2022-06-20

Review 6.  The MOGE(S) classification for cardiomyopathies: current status and future outlook.

Authors:  Julian G Westphal; Angelos G Rigopoulos; Constantinos Bakogiannis; Sarah E Ludwig; Sophie Mavrogeni; Boris Bigalke; Torsten Doenst; Matthias Pauschinger; Carsten Tschöpe; P Christian Schulze; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

7.  In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease.

Authors:  Nadine Althof; Stephanie Harkins; Christopher C Kemball; Claudia T Flynn; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

8.  Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy.

Authors:  Heinz-Peter Schultheiss; Cornelia Piper; Olaf Sowade; Finn Waagstein; Joachim-Friedrich Kapp; Karl Wegscheider; Georg Groetzbach; Matthias Pauschinger; Felicitas Escher; Eloisa Arbustini; Harald Siedentop; Uwe Kuehl
Journal:  Clin Res Cardiol       Date:  2016-04-25       Impact factor: 5.460

9.  Cell type-specific roles of PAR1 in Coxsackievirus B3 infection.

Authors:  Michael F Bode; Clare M Schmedes; Grant J Egnatz; Vanthana Bharathi; Yohei M Hisada; David Martinez; Tomohiro Kawano; Alice Weithauser; Leah Rosenfeldt; Ursula Rauch; Joseph S Palumbo; Silvio Antoniak; Nigel Mackman
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.996

10.  Targeted treatment in viral-associated inflammatory cardiomyopathy.

Authors:  Ahmad Amin; Sepideh Taghavi; Maryam Chenaghlou; Elahe Zare; Monireh Kamali; Nasim Naderi
Journal:  Clin Case Rep       Date:  2021-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.